253 related articles for article (PubMed ID: 5575433)
1. Demonstration of the specific transplantation tumour antigen in carcinoma BO-IV in vivo.
Rejthar A; Wotke J
Neoplasma; 1971; 18(1):27-31. PubMed ID: 5575433
[No Abstract] [Full Text] [Related]
2. Detection of tumour-associated transplantation antigen of BO-IV carcinoma on somatic cells of tumour-free syngeneic mice. I. Demonstration of this antigen on spleen cells.
Rejthar A
Folia Biol (Praha); 1972; 18(2):132-8. PubMed ID: 4554741
[No Abstract] [Full Text] [Related]
3. Detection of tumour-associated transplantation antigen of BO-IV carcinoma on somatic cells of tumour-free syngeneic mice. 3. Demonstration of this antigen on the lymphoreticular system of adult mice.
Rejthar A; Wotke J
Folia Biol (Praha); 1974; 20(4):244-51. PubMed ID: 4472054
[No Abstract] [Full Text] [Related]
4. Studies on immunization of golden hamsters to transplantable melanomas.
Bomirski A
Arch Immunol Ther Exp (Warsz); 1970; 18(4):481-90. PubMed ID: 5483305
[No Abstract] [Full Text] [Related]
5. On the mechanisms of tumour facilitation and tumour inhibition. Effect of the local graft-versus-host reaction.
Medzihrský J
Neoplasma; 1969; 16(1):3-10. PubMed ID: 5815024
[No Abstract] [Full Text] [Related]
6. Inhibition of subcutaneously growing line 1 carcinomas due to metastatic spread.
Yuhas JM; Pazmiño NH
Cancer Res; 1974 Aug; 34(8):2005-10. PubMed ID: 4366938
[No Abstract] [Full Text] [Related]
7. Protection of C58 mice by normal murine tissues against transplantable leukemia, line Ib.
Han IH; Johnson AG; Murphy WH
J Natl Cancer Inst; 1969 May; 42(5):815-24. PubMed ID: 5785010
[No Abstract] [Full Text] [Related]
8. Resistance and susceptibility to tumours. 3. Effect of some derivatives from immunized animals on the Bo4 and Ehrlich carcinomas.
Dvorák R; Chlumecký J
Neoplasma; 1969; 16(6):613-24. PubMed ID: 5369028
[No Abstract] [Full Text] [Related]
9. [Influence of antigen quantity on the immunity induced by specific antigens of syngenic solid murine tumors].
Donner M; Burg C
C R Seances Soc Biol Fil; 1970; 164(8):1832-6. PubMed ID: 4253216
[No Abstract] [Full Text] [Related]
10. Influence of X irradiation and the milk agent on growth of transplanted mouse mammary tumors.
Prehn RT
J Natl Cancer Inst; 1969 Dec; 43(6):1215-20. PubMed ID: 4319246
[No Abstract] [Full Text] [Related]
11. Detection of tumor-associated transplantation antigen of BO-IV carcinoma on somatic cells of tumor-free syngeneic mice. IV. Search for this antigen on syngeneic embryonic tissues.
Rejthar A
Folia Biol (Praha); 1974; 20(4):252-7. PubMed ID: 4412745
[No Abstract] [Full Text] [Related]
12. [Immunologic response to transplantable specific antigens in experimental tumors].
Porwit-Bóbr Z
Postepy Hig Med Dosw; 1971; 25(1):25-36. PubMed ID: 4932042
[No Abstract] [Full Text] [Related]
13. Humoral and cellular immune factors in the systemic control of artifically induced metastases in C3Hf mice.
Vaage J
Cancer Res; 1973 Aug; 33(8):1957-65. PubMed ID: 4720805
[No Abstract] [Full Text] [Related]
14. Immune response against apparently host-compatible transplantable tumors.
Manson LA; Goldstein L; Thorn R; Palmer J
Transplant Proc; 1975 Jun; 7(2):161-4. PubMed ID: 1129841
[No Abstract] [Full Text] [Related]
15. [Autologic reaction of serum precipitation in mice of the C3HA line with extracts of normal tissue and hepatomas].
Shevchenko VS
Vopr Onkol; 1966; 12(10):68-73. PubMed ID: 4301435
[No Abstract] [Full Text] [Related]
16. Destruction of tumor as an "innocent bystander" in an immune response specifically directed against nontumor antigens.
Prehn RT
Isr J Med Sci; 1973 Mar; 9(3):375-9. PubMed ID: 4145462
[No Abstract] [Full Text] [Related]
17. Tumor immunity in hamsters immunized with fetal tissues.
Coggin JH; Ambrose KR; Bellomy BB; Anderson NG
J Immunol; 1971 Aug; 107(2):526-33. PubMed ID: 4328010
[No Abstract] [Full Text] [Related]
18. [Immunity in transplantation of rat ascitic tumors in mice].
Novikov DK; Adamenko GP; Novikova VI
Vopr Onkol; 1972; 18(7):77-81. PubMed ID: 4342629
[No Abstract] [Full Text] [Related]
19. The immune recognition of TA3 tumors, its facilitation by endotoxin, and abrogation by ascites fluid.
Grohsman J; Nowotny A
J Immunol; 1972 Nov; 109(5):1090-5. PubMed ID: 4562425
[No Abstract] [Full Text] [Related]
20. Depression of antilymphoma allograft reactivity by tumor-associated factors.
Bonmassar E; Bonmassar A; Goldin A; Cudkowicz G
Cancer Res; 1973 May; 33(5):1054-61. PubMed ID: 4703118
[No Abstract] [Full Text] [Related]
[Next] [New Search]
